Where is TScan headquartered?

TScan is located in Waltham, MA.

Who invested in TScan?

TScan has 13 investors including Geekdom Fund And Geekdom Fund.

When was the last funding round for TScan?

TScan closed its lastf unding roundon Jul 19, 2017 from a Convertible Note round.

Company Information
Company Timeline (Coming Soon)

tscan.com

TScan

TScan is a Massachusetts-based biopharmaceutical company that develops and commercializes T-cell therapies for the treatment of cancer.

Business Model:

Revenue: $13.3M

Employees: 51-200

Geographic Data

Address: 830 Winter Street

City: Waltham

State: MA

Zip: 02451

Country: US

Financial Info

Stage:

series c

Raised Last:

$100M

Raised Total:

$138M

Social

Twitter

Crunchbase

Metrics

2,705,772Website Global Rank

6,446Website Monthly Traffic

Twitter Followers

Description

TScan is a Massachusetts-based biopharmaceutical company that develops and commercializes T-cell therapies for the treatment of cancer.

Contact Phone:
+18573999500

Contact Email:

IPO Details

TScan went public on 7/15/2021 on the NASDAQ

Listed Exchange:
NASDAQ

IPO Date:
7/15/2021

IPO Valuation:
$359M

Ticker Symbol:
TCRX

IPO Price:
$15/share

Amount Raised:
$100M

Live

Opened: -/share

EBITDA	-
Total Cash	-
Total Debt	-
Total Revenue	-
Total Profit (Gross)	-
PE Ratio	-

Investments

Announced Date	Company	Transaction	Money Raised

Funding Rounds

Announced Date	Transaction	Number of Investors	Money Raised	Lead Investors
1/2021	Series C	8	$100M	RA Capital Management Longwood Fund Novartis Venture Fund Bessemer Venture Partners Pitango Venture Capital BlackRock 6 Dimensions Capital GV RA Capital Management Longwood Fund Novartis Venture Fund Bessemer Venture Partners Pitango Venture Capital BlackRock 6 Dimensions Capital GV
7/2019	Series B	5	-	Novartis Venture Fund Novartis Institutes for Biomedical Research Longwood Fund GV Bessemer Venture Partners Novartis Venture Fund Novartis Institutes for Biomedical Research Longwood Fund GV Bessemer Venture Partners
9/2022	Post-IPO Debt		$60M	K2 HealthVentures K2 HealthVentures
1/2020	Series B		$11.7M	Pitango Venture Capital Astellas Venture Management 6 Dimensions Capital Longwood Fund Bessemer Venture Partners GV Novartis Venture Fund
6/2018	Series A		$2.5M
7/2021	IPO		$100M
1/2020	Series B	8	$35M	Novartis Institutes for Biomedical Research Astellas Venture Management Pitango VC Novartis Venture Fund Longwood Fund GV Bessemer Venture Partners 6 Dimensions Capital Novartis Institutes for Biomedical Research Astellas Venture Management
7/2019	Series B		$23.3M	Bessemer Venture Partners Google Ventures Longwood Fund Novartis Venture Funds
9/2022	Post-IPO Debt		$60M
7/2019	Series B	5	-

Acquisitions

Announced Date	Name	Price

Employee Demographics

Employee Departments

Employee States

Similar Companies

Uniview Singapore VEID	Revenue: 0 - 100000 Employees: Industry: Software	Details
Konkuk University Medical Center	Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education	Details
Daemon Technologies	Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain	Details
Ace International Trade	Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial	Details
An Hòa Communications	Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising	Details